The Anglonordic Medtech Conference continue its success
The Anglo-Nordic region continues to be one of the fastest growing medtech regions in the world and the Anglonordic Medtech Conference provides the ideal one-stop opportunity to discover, collaborate and invest in this success. By invitation only, the select audience is restricted to decision makers representing drug discovery and medtech companies from the Anglo-Nordic regions and international pharmaceutical and investment firms. The conference consists of four areas that have simultaneous activities.
The four areas are; the Main Conference Room & Aescap Venture Investment Room, the Exhibition Room (for SME only), the One-to-One Meetings Area and the Exhibition/Lounge Area. The conference ends with The Reception on the evening (12th June) at Canada House on Trafalgar Square in London. Delegates from the Anglonordic Biotech Conference X are also invited to The Reception.
Be a conference sponsor!
The conference invites you to be part of this successful event. Through an understanding of your corporate objectives, we can develop a package of benefits tailored to meet your individual needs and budget.
350 decision makers at The Reception
Celebrating the Anglonordic Biotech Conference 10th anniversary; we expect The Reception at Canada House on Trafalgar Square to be something extra this year. Delegates from both conferences are invited and in total we anticipate more than 80 European investors to attend and to reach the venue's maximum capacity of 350 delegates, representing the European Life Science Industry.
